Antonio J. Viana, who serves as a director at Arteris, Inc. (NASDAQ:AIP), recently disposed of a substantial amount of company shares. Over two days in May 2026, Mr. Viana sold 40,000 units of the firm's common stock, totaling $1,446,963.
The sales were executed on May 13 and May 14, 2026. During this period, the sale prices for the shares ranged from a low of $34.0595 to a high of $38.00 per share. This activity takes place against a backdrop where Arteris stock is trading close to its 52-week peak valuation of $38.47, with current market pricing observed at $37.34.
The company's stock has demonstrated considerable upward momentum, having surged by 397% over the preceding year. However, some analysis from InvestingPro suggests that the company may be trading at an elevated valuation level given its current price point.
Details of Share Sales
On May 13th, Mr. Viana conducted multiple transactions through the Viana Family Trust. First, the trust disposed of 15,538 shares at a weighted average price of $34.0595. These specific sales involved varying transaction prices between $34.00 and $34.27.
Later that same day, an additional 4,462 shares were sold by the trust with a weighted average price of $35.3534. The individual sale prices for these units ranged from $35.00 to $35.43. It is important to note that both sets of sales on May 13th were executed under the framework of a Rule 10b5-1 trading plan, which Mr. Viana had originally established on June 10, 2025.
The subsequent day, May 14, saw the trust execute another significant sale, disposing of 20,000 shares at a fixed price of $38.00 per share, also carried out in accordance with the established 10b5-1 plan.
Current Holdings and Recent Corporate Performance
Following these transactions, Mr. Viana's indirect stake in Arteris common stock through the Viana Family Trust stands at 64,620 shares. In addition to this trust holding, he maintains a direct ownership of 20,840 shares.
The timing of these sales contrasts with other recent positive corporate developments for Arteris Inc. The company recently reported financial outcomes for the first quarter of 2026 that surpassed market expectations. Specifically, Arteris recorded an earnings per share (EPS) of -$0.03, which was a favorable improvement compared to the anticipated figure of -$0.07. Furthermore, revenue reached $22.94 million, exceeding the forecast of $21.03 million.
Following these strong results, TD Cowen increased its price target for Arteris shares substantially, raising it to $40 from a previous level of $22. While maintaining an 'Buy' rating, the firm highlighted the company’s robust performance during Q1 and provided an increase in guidance for both the second quarter and the full year 2026. These developments underscore Arteris’s growth trajectory within critical sectors such as AI and automotive. The recent analysis from TD Cowen suggests a high degree of confidence in Arteris's continued future performance, offering valuable insights for investors tracking the company's progress.